The overall objectives of this proposal are to evaluate the role of the nervous system [i.e., cholinergic, adrenergic, and dopaminergic innervation], hormones (i.e., gastrin), and toxic agents [carbon tetrachloride (CCl4)] in the regulation of secretion, growth, and apoptosis of distinct subpopulations of small and large cholangiocytes or intrahepatic bile duct units (IBDU) from normal and bile duct ligated (BDL) rats. This hypothesis is based upon our previous studies and preliminary data showing that: (i) the cholinergic, adrenergic, and dopaminergic system, and the hormone gastrin modifies cholangiocyte growth and secretion through up- or down-regulation of the Ca2+-dependent PKC system; and (ii) CCl4-induced damage of large hormone-responsive ducts is regulated by the PKC system. To evaluate our hypothesis, three specific aims are proposed : (i) to test the hypothesis that cholinergic, adrenergic, and dopaminergic innervation regulates cholangiocyte growth, and secretion of different sized ducts; (ii) to test the hypothesis that gastrin decreases growth in hyperplastic rat cholangiocytes and in cholangiocarcinoma cell lines through activation and cytoskeleton to membrane translocadon of Ca2+-dependent PKC alpha; and (iii) to test the hypothesis that CCl4-induced duct injury response consisting of cholangiocyte apoptosis followed by cholangiocyte proliferation is dependent on the PKC pathway. In BDL rats, proliferative and secretory processes of small and large cholangiocytes originating from small and large ducts, respectively will be evaluated. Furthermore, small and large IBDU will also be employed to confirm that our observations in different sizes of cholangiocytes is also present in the corresponding sized ducts. These studies will evaluate both in vivo and in vitro the differential proliferative, and secretory responses of small and large cholangiocytes or IBDU to specific cholinergic, adrenergic, and dopaminergic agonists/antagonists, gastrin, or CCl4 treatment. The results should provide new insight into the mechanisms of cholangiocyte growth, and secretion of different sized ducts.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK054811-02
Application #
6402591
Study Section
General Medicine A Subcommittee 2 (GMA)
Program Officer
Doo, Edward
Project Start
2000-09-01
Project End
2005-08-31
Budget Start
2001-09-01
Budget End
2002-08-31
Support Year
2
Fiscal Year
2001
Total Cost
$174,089
Indirect Cost
Name
Texas A&M University
Department
Physiology
Type
Schools of Medicine
DUNS #
City
College Station
State
TX
Country
United States
Zip Code
77845
Wu, Nan; Meng, Fanyin; Zhou, Tianhao et al. (2018) The Secretin/Secretin Receptor Axis Modulates Ductular Reaction and Liver Fibrosis through Changes in Transforming Growth Factor-?1-Mediated Biliary Senescence. Am J Pathol 188:2264-2280
Zhou, Tianhao; Wu, Nan; Meng, Fanyin et al. (2018) Knockout of secretin receptor reduces biliary damage and liver fibrosis in Mdr2-/- mice by diminishing senescence of cholangiocytes. Lab Invest 98:1449-1464
Ehrlich, Laurent; Scrushy, Marinda; Meng, Fanyin et al. (2018) Biliary epithelium: A neuroendocrine compartment in cholestatic liver disease. Clin Res Hepatol Gastroenterol 42:296-305
Sato, Keisaku; Meng, Fanyin; Venter, Julie et al. (2018) Author Correction: The role of the secretin/secretin receptor axis in inflammatory cholangiocyte communication via extracellular vesicles. Sci Rep 8:11238
Sato, Keisaku; Meng, Fanyin; Giang, Thao et al. (2018) Mechanisms of cholangiocyte responses to injury. Biochim Biophys Acta Mol Basis Dis 1864:1262-1269
Luo, Xianjun; Li, Honggui; Ma, Linqiang et al. (2018) Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice. Gastroenterology 155:1971-1984.e4
Cai, Yuli; Li, Honggui; Liu, Mengyang et al. (2018) Disruption of adenosine 2A receptor exacerbates NAFLD through increasing inflammatory responses and SREBP1c activity. Hepatology 68:48-61
Wu, Nan; Meng, Fanyin; Zhou, Tianhao et al. (2017) Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulation. FASEB J 31:4305-4324
Wan, Ying; Meng, Fanyin; Wu, Nan et al. (2017) Substance P increases liver fibrosis by differential changes in senescence of cholangiocytes and hepatic stellate cells. Hepatology 66:528-541
Ehrlich, Laurent; Hall, Chad; Meng, Fanyin et al. (2017) A Review of the Scaffold Protein Menin and its Role in Hepatobiliary Pathology. Gene Expr 17:251-263

Showing the most recent 10 out of 88 publications